US Broker Ratings

Amedisys Inc (AMED) Stock Analysis: Navigating the Healthcare Sector with a Forward P/E of 19.07

Amedisys Inc (NASDAQ: AMED), a key player in the healthcare sector, is garnering attention from investors seeking opportunities in the medical care facilities industry. Headquartered in..

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: A Promising 69% Upside Potential in the Biotech Arena

Xenon Pharmaceuticals Inc. (NASDAQ: XENE), a pioneering force in the biotechnology sector, is captivating investor attention with its robust pipeline of neurological and psychiatric therapeutics. With..

Evotec SE (EVO) Stock Analysis: A Glimpse into Its 47.51% Potential Upside

Evotec SE (NASDAQ: EVO) is a prominent player in the healthcare sector, specializing in drug discovery and development. With a market capitalization of $1.47 billion, this..

Liquidia Corporation (LQDA) Investor Outlook: Analyzing a 109% Upside Potential in the Biotech Space

Liquidia Corporation (NASDAQ: LQDA), a promising player in the biotechnology sector, is garnering significant attention from investors due to its potential upside of 109.25%. Based in..

Belite Bio, Inc (BLTE) Stock Analysis: Exploring a Potential 33.69% Upside in the Biotech Sector

Belite Bio, Inc (NASDAQ: BLTE) is making waves in the biotechnology sector, capturing the attention of investors with its innovative approach to tackling retinal degenerative diseases...

Perrigo Company plc (PRGO) Stock Report: Exploring a Potential 33% Upside in Healthcare

For investors with a keen interest in the healthcare sector, Perrigo Company plc (NYSE: PRGO) presents a compelling opportunity. Based in Dublin, Ireland, Perrigo operates as..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 178.67% Upside Potential in Biotech

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a burgeoning player in the biotechnology sector, is capturing investor attention with its impressive potential upside of 178.67%, according to analyst..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 28.75% Potential Upside in the Biotech Sector

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) has emerged as a compelling proposition for investors within the biotechnology sector, boasting a market capitalization of $2.64 billion. This biopharmaceutical..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare with a 3.83% Dividend Yield

For investors in the healthcare sector, Premier, Inc. (NASDAQ: PINC) presents a compelling study in contrasts. As a leading healthcare improvement company, Premier operates through its..

Vericel Corporation (VCEL) Stock Analysis: A 49% Upside Potential in the Biotech Sector

Vericel Corporation (NASDAQ: VCEL), a notable player in the biotechnology industry, is currently capturing the attention of investors with its promising outlook. With a market capitalization..

Galapagos NV (GLPG) Stock Analysis: Navigating the Biotech Landscape with a 20% Revenue Growth

Galapagos NV (NASDAQ: GLPG), a prominent player in the biotechnology sector, continues to capture investor attention amid its strategic focus on oncology and immunology. Headquartered in..

Immunocore Holdings plc (IMCR) Stock Analysis: Uncovering a 76% Potential Upside in Biotech

Immunocore Holdings plc (NASDAQ: IMCR) stands as a notable player in the biotechnology sector, a field known for its rapid innovation and potential for high returns...

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: 30% Upside Potential Amid CNS Drug Innovations

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) presents a compelling opportunity for investors, driven by its strategic positioning in the biotechnology sector with a focus on central nervous..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 14.84% Potential Upside in the CNS Treatment Market

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a biopharmaceutical company specializing in the treatment of central nervous system (CNS) diseases, presents an intriguing opportunity for investors with its..

Haemonetics Corporation (HAE) Stock Analysis: Unpacking an 18% Potential Upside in the Medical Devices Sector

Haemonetics Corporation (NYSE: HAE) stands as a prominent player in the medical devices industry, specializing in hospital technology solutions that span from plasma collection to advanced..

Guardian Pharmacy Services, Inc. (GRDN) Stock Analysis: A Look at Its 34% Potential Upside

Guardian Pharmacy Services, Inc. (GRDN), a significant player in the healthcare sector, specializes in providing technology-enabled pharmacy services to long-term care facilities (LTCFs) across the United..

CONMED Corporation (CNMD)

⚠️ No article content returned.

..

Clover Health Investments (CLOV) Stock Analysis: Exploring a 56% Potential Upside

Clover Health Investments, Corp (CLOV), a key player in the healthcare plans industry, is garnering attention from investors with its attractive potential upside of 56.25%. As..

SS Innovations International (SSII) Stock Report: A Closer Look at This Healthcare Innovator’s Financial Landscape

SS Innovations International Inc. (SSII), a trailblazer in the healthcare sector, is carving out a niche in the medical devices industry. As a commercial-stage surgical robotics..

Ascentage Pharma Group International (AAPG): A High-Growth Biotech Stock with Challenging Prospects

Ascentage Pharma Group International (AAPG), a clinical-stage biotechnology firm based in Suzhou, China, is making waves in the healthcare sector with its focus on developing innovative..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds